TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 119 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2015. The put-call ratio across all filers is 4.19 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $404,000 | +19.2% | 4,590 | +2.2% | 0.02% | +17.6% |
| Q3 2019 | $339,000 | +8.7% | 4,490 | +55.4% | 0.02% | -10.5% |
| Q1 2019 | $312,000 | -39.4% | 2,890 | -52.5% | 0.02% | -42.4% |
| Q4 2018 | $515,000 | +5.1% | 6,090 | +22.0% | 0.03% | +50.0% |
| Q3 2018 | $490,000 | -38.5% | 4,990 | -27.6% | 0.02% | -31.2% |
| Q2 2018 | $797,000 | -24.5% | 6,890 | -35.5% | 0.03% | -23.8% |
| Q1 2018 | $1,055,000 | +40.3% | 10,690 | +48.7% | 0.04% | +27.3% |
| Q4 2017 | $752,000 | -61.3% | 7,190 | -47.0% | 0.03% | -62.1% |
| Q1 2016 | $1,941,000 | +176.1% | 13,555 | +197.6% | 0.09% | +163.6% |
| Q4 2015 | $703,000 | -65.5% | 4,555 | -67.9% | 0.03% | -51.5% |
| Q2 2015 | $2,039,000 | +21.8% | 14,194 | +20.5% | 0.07% | +17.2% |
| Q1 2015 | $1,674,000 | +327.0% | 11,778 | +233.2% | 0.06% | +176.2% |
| Q1 2014 | $392,000 | – | 3,535 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |